創亞化工(上海)有限公司是一家致力于生命科學和生物技術領域的高科技企業。公司由在國內科研試劑領域有著十幾年從業經驗的專業技術團隊和企業管理團隊組建而成,專門從事以抗體、細胞因子、免疫檢測試劑盒等免疫學產品為主的生物試劑的研發與銷售。
*Beckman A63881的磁珠 現貨,moltox 11-101.5等現貨,transgenomic 706020/706025現貨,Megazyme的大部分現貨,LIST現貨,、ALZET大量現貨,
Avanti 、tedpella 、BioLegend、Polyplus、jena bioscience、Mattek、MRC-Holland、polysciences、enzo、novus、TOCRIS、CAYMAN、Neuro Probe、cyguns、eylabs、NIBSC、chondrex、lc laboratories、BTI、etonbio
NeuroMab上海代理-創亞化工
NeuroMab上海代理-創亞化工
NeuroMab上海代理-創亞化工
NeuroMab上海代理-創亞化工
創亞化工(上海)有限公司是一家致力于生命科學和生物技術領域的高科技企業。公司由在國內科研試劑領域有著十幾年從業經驗的專業技術團隊和企業管理團隊組建而成,專門從事以抗體、細胞因子、免疫檢測試劑盒等免疫學產品為主的生物試劑的研發與銷售。
UC Davis / NIH NeuroMab Facility是由國立衛生研究院(NIH)資助的國家單克隆抗體產生資源。 UC Davis / NIH NeuroMab設施的使命是提供一種*的基于神經科學的方法來生成優化用于哺乳動物腦中的小鼠單克隆抗體(NeuroMabs)。 NeuroMab從用對應于如從基因組和其他大規模克隆努力預測的神經元蛋白質組分的合成和重組免疫原免疫的小鼠產生。人,靈長類動物和非靈長類哺乳動物腦的綜合生物化學和免疫組織化學分析被并入UC Davis / NIH NeuroMab設施篩選程序。這產生了優化用于腦(即,NeuroMab)的小鼠mAb的子集:用于基于免疫組織化學的成人,發育和病理腦樣品中的蛋白質定位的成像研究,用于亞基組成的生物化學分析和翻譯后修飾天然腦蛋白,以及天然腦蛋白網絡的蛋白質組學分析。
5-formylcytidine | Epigenetics | N358/68 | ---- | N358_68.pdf | 20121219 | IgG1 | ND | ND | ND | ND | 73-349 | QC testing | RRID:AB_2315792 | RRID:AB_2315793 |
5-hydroxymethylcytidine | Epigenetics | N297/59 | ---- | N297_59.pdf | 20111006 | IgG2a | ND | ND | ND | ND | 73-268 | 75-268 | RRID:AB_11000723 | RRID:AB_11001670 |
6xHis | Tag | N144/14 | ---- | N144_14.pdf | 20100823 | IgG1 | NA | NA | NA | 73-169 | 75-169 | RRID:AB_10671171 | RRID:AB_10673446 |
ADAM11 | Receptors | Q9R1V4 | N441/35 | ADAM11 | N441_35.pdf | 20150925 | IgG2b | ND | 73-432 | 75-432 | RRID:AB_2532073 | RRID:AB_2636850 |
ADAM22 (cytoplasmic) | Receptors | Q9R1V6 | N46/30 | ADAM22 | N46_30.pdf | 20120307 | IgG2b | 73-083 | 75-083 | RRID:AB_10673957 | RRID:AB_10675128 |
ADAM22 (extracellular) | Receptors | Q9R1V6 | N57/2 | ADAM22 | N57_2.pdf | 20120307 | IgG1 | 73-093 | 75-093 | RRID:AB_10671172 | RRID:AB_2223817 |
AGPS neo-epitope | Rare Disease | O00116 | N444/63 | AGPS | N444_63.pdf | 20151016 | IgG1 | ND | ND | 73-434 | 75-434 | RRID:AB_2532090 | RRID:AB_2629423 |
Aldh1L1 (blotting) | Other | P28037 | N103/39 | ALDH1L1 | N103_39.pdf | 20100823 | IgG1 | ND | ND | 73-140 | 75-140 | RRID:AB_10673447 | RRID:AB_10673448 |
Aldh1L1 (staining) | Other | P28037 | N103/31 | ALDH1L1 | N103_31.pdf | 20100823 | IgG1 | ND | 73-164 | 75-164 | RRID:AB_10673958 | RRID:AB_10671695 |
Alg13 | Rare Disease | Q9D8C3-2 | N442/28 | ALG13 | N442_28.pdf | 20160303 | IgG2b | ND | 73-441 | 75-441 | RRID:AB_2566821 | RRID:AB_2632413 |
Alpha-2C adrenergic receptor | Receptors | P18825 | N330A/80 | ADRA2C | N330A_80.pdf | 20120504 | IgG1 | ND | 73-302 | 75-302 | RRID:AB_2315796 | RRID:AB_2315797 |
Alpha-2C adrenergic receptor | Receptors | P18825 | N330A/51 | ADRA2C | N330A_51.pdf | 20120504 | IgG2a | ND | 73-300 | 75-300 | RRID:AB_2315794 | RRID:AB_2315795 |
AMIGO-1 | Other | Q86WK6 | L86/33 | AMIGO1 | L86_33.pdf | 20130513 | IgG2a | 73-317 | 75-317 | RRID:AB_2315798 | RRID:AB_2315765 |
AMIGO-1 | Other | Q86WK6 | L86/36 | AMIGO1 | L86_36.pdf | 20130513 | IgG1 | 73-318 | 75-318 | RRID:AB_2315799 | RRID:AB_2315800 |
AMIGO-1 | Other | Q86WK6 | L86A/37 | AMIGO1 | L86A_37.pdf | 20130513 | IgG2b | 73-329 | 75-329 | RRID:AB_2315801 | RRID:AB_2315802 |
Ankyrin-B | Scaffolds | Q01484 | N105/13 | ANK2 | N105_13.pdf | 20100823 | IgG1 | ND | 73-144 | 75-144 | RRID:AB_10675129 | RRID:AB_10673094 |
Ankyrin-B | Scaffolds | Q01484 | N105/17 | ANK2 | N105_17.pdf | 20130416 | IgG2a | ND | 73-145 | 75-145 | RRID:AB_10674432 | RRID:AB_2057705 |
Ankyrin-G (blotting) | Scaffolds | E9PE32 | N106/20 | ANK3 | N106_20.pdf | 20160705 | IgG1 | ND | 73-187 | 75-187 | RRID:AB_10674433 | RRID:AB_2057718 |
Ankyrin-G (staining) | Scaffolds | E9PE32 | N106/36 | ANK3 | N106_36.pdf | 20120920 | IgG2a | ND | 73-146 | 75-146 | RRID:AB_10697718 | RRID:AB_10673030 |
Ankyrin-G (staining) | Scaffolds | E9PE32 | N106/65 | ANK3 | N106_65.pdf | 20170208 | IgG2b | ND | 73-147 | 75-147 | RRID:AB_10673449 | RRID:AB_10675130 |
Ankyrin-G (staining) | Scaffolds | E9PE32 | N106/43 | ANK3 | N106_43.pdf | 20120920 | IgG1 | ND | ND | 73-342 | N/A | RRID:AB_2315803 | RRID: |
Ankyrin-R | Scaffolds | P16157 | N388A/10 | ANK1 | N388A_10.pdf | 20140605 | IgG2b | 73-380 | 75-380 | RRID:AB_2336901 | RRID:AB_2491109 |
Ankyrin-R/G | Scaffolds | N388A/27 | ---- | N388A_27.pdf | 20150408 | IgG2b | NA | 73-415 | 75-415 | RRID:AB_2491183 | RRID:AB_2493098 |
ANO5/TMEM16E | Ion channels | Q75V66 | N421A/85 | ANO5 | N421A_85.pdf | 20150409 | IgG1 | NA | NA | NA | 73-410 | 75-410 | RRID:AB_2491107 | RRID:AB_2531893 |
ANO6/TMEM16F | Ion channels | Q4KMQ2 | N429/19 | ANO6 | N429_19.pdf | 20150409 | IgG2b | 73-418 | QC testing | RRID:AB_2491186 | RRID: |
ARHGAP4 | Other | Q8VHL8 | N290B/25 | ARHGAP4 | N290B_25.pdf | 20120507 | IgG1 | ND | 73-299 | 75-299 | RRID:AB_2315804 | RRID:AB_2315805 |
Arl13b | Rare Disease | Q640N2 | N295B/66 | ARL13B | N295B_66.pdf | 20130105 | IgG2a | 73-287 | 75-287 | RRID:AB_11000053 | RRID:AB_11001586 |
Arx | Other | O35085 | N411/51 | ARX | N411_51.pdf | 20150818 | IgG1 | 73-402 | 75-402 | RRID:AB_2491076 | RRID:AB_2491188 |
ASIC1 | Ion channels | Q6NXK8 | N271/44 | ASIC1 | N271_44.pdf | 20130213 | IgG1 | 73-277 | 75-277 | RRID:AB_11000719 | RRID:AB_11030370 |
ATAT1 | Rare Disease | Q5SQI0 | N347/42 | ATAT1 | N347_42.pdf | 20150710 | IgG1 | 73-426 | 75-426 | RRID:AB_2531888 | RRID: |
Ataxin-1, 11NQ | Rare Disease | P54254 | N76/8 | ATXN1 | N76_8.pdf | 20100823 | IgG2b | 73-117 | 75-117 | RRID:AB_10671173 | RRID:AB_10673960 |
Ataxin-1, 11NQ | Rare Disease | P54254 | N76/3 | ATXN1 | N76_3.pdf | 20100823 | IgG1 | 73-122 | 75-122 | RRID:AB_10671696 | RRID:AB_2061163 |
Ataxin-1, WT | Rare Disease | P54254 | N65/37 | ATXN1 | N65_37.pdf | 20100823 | IgG1 | ND | ND | ND | 73-102 | 75-102 | RRID:AB_10675131 | RRID:AB_10675132 |
ATF4 | Other | P18848 | N360A/24 | ATF4 | N360A_24.pdf | 20121221 | IgG2a | ND | 73-345 | 75-345 | RRID:AB_2315806 | RRID:AB_2315807 |
BAF53a | Other | O96019 | N336B/83 | ACTL6A | N336B_83.pdf | 20120716 | IgG2b | ND | ND | ND | 73-330 | 75-330 | RRID:AB_2315808 | RRID:AB_2315809 |
BAF53b | Other | O94805 | N332B/15 | ACTL6B | N332B_15.pdf | 20120730 | IgG1 | 73-311 | 75-311 | RRID:AB_2315810 | RRID:AB_2315811 |
BBS3/Arl6 | Rare Disease | Q9H0F7 | N302/10 | ARL6 | N302_10.pdf | 20120507 | IgG1 | ND | 73-270 | 75-270 | RRID:AB_10999750 | RRID:AB |